11th Nov 2015 16:40
LONDON (Alliance News) - Abcam PLC, a life science research company, on Wednesday said that Chief Executive Alan Hirzel has bought GBP19,343 worth of shares in the company in the wake of the acquisition of US-based AxioMx Inc for up to USD45.0 million.
Earlier on Wednesday Abcam said it had struck a deal to acquire AxioMx, a company which makes a platform to produce recombinant monoclonal antibodies which will complement Abcam's existing production capabilities, Abcam said.
"The acquisition of AxioMx is in line with our strategy of acquiring businesses which enable Abcam to increase the supply of high quality products generated from our own innovation, and allows us to respond more quickly to our customers' needs," Hirzel said earlier on Wednesday.
Hirzel bought 3,335 shares at 580.0 pence each on Wednesday, the company said, giving him a total of 26,540 shares.
That shareholding gives the chief executive 0.01% ownership of Abcam.
Separately, Suzanne Smith, chief legal officer and company secretary, bought 864 shares at 578.1p on the same day.
Smith now owns 4,269 shares in the company, equivalent to a 0.002% stake.
Shares in Abcam closed up 0.9% at 578.00p late Wednesday.
By Samuel Agini; [email protected]; @samuelagini
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
ABC.L